August 25, 2015
Meet Jardiance: the First Antidiabetic Drug To Reduce Cardiovascular Risk
The obesity epidemic and a progressively more sedentary lifestyle have contributed to type 2 diabetes (T2D) becoming increasingly more common. Cardiovascular (CV) disease is the major cause of mortality among patients with T2D, accounting for 60–80% of deaths in these patients. Despite recent studies demonstrating the benefit of a proper glycemic control in ...
LEARN MORE
August 18, 2015
Novel Drug Formulation Delivers Immunotherapy To Ovarian Cancer Cells
Ovarian cancer is the fifth most common cancer in women. Worldwide, nearly 239,000 women were diagnosed with ovarian ...
LEARN MORE
August 11, 2015
New Immunotherapy Approach Locks The Immune Cells In A Switched On Mode
Checkpoint inhibitors are the most heralded drugs in oncology. They work by removing the brake on the immune system to ...
LEARN MORE
August 4, 2015
Personalized Medicine for Triple Negative Breast Cancer Could Become Reality Following New Biomarker Discovery
Breast cancer is the most frequently diagnosed cancer type and the second leading cause of cancer death in women ...
LEARN MORE
